NTRK重排甲状腺癌的细胞形态学特征
该研究回顾性分析了19例NTRK重排甲状腺癌(NRTC)患者的21份细针穿刺(FNA)标本,其中14例有可用细胞学材料。超声多表现为低回声、边界不清和微钙化;细胞学常见混合结构模式(79%)和纤维化(93%),多数FNA分类为可疑恶性或恶性(89%)。结论认为NRTC无一致细胞形态学特征,但混合结构模式、显著纤维化及特定胞质/核特征可提示NRTC,结合细胞块BRAFV600E免疫组化阴性有助于选择分子检测。
要点
- NRTC的FNA细胞学多分类为可疑恶性或恶性(89%)。
- 混合结构模式(79%)和纤维化(93%)是常见细胞形态特征。
- 细胞块BRAFV600E免疫组化阴性时,应考虑分子检测以识别NRTC。
核心结论
- NRTC无一致细胞形态学特征,但混合结构模式、显著纤维化及特定胞质或核特征可提示NRTC。
- 当细胞块BRAFV600E免疫组化阴性时,上述特征有助于选择病例进行分子检测以识别NRTC。
研究设计与样本
- 机构内NRTC FNA队列,共21份标本来自19例患者,平均年龄42岁,女性与男性比为2.2:1。
- 对14例有可用材料的患者回顾了酒精固定巴氏涂片和液基制片,并对所有19例患者后续切除标本进行了组织学回顾。
- 影像和临床数据通过电子病历获取。
主要发现
- 超声上NRTC表现为低回声(87%)、以实性为主(53%)、中央血供有限(27%)、边界不清(67%)和微钙化(67%)。
- 细胞形态学特征包括混合结构模式(79%)、纤维化(93%)、嗜酸性和空泡状胞质(分别为36%和43%)、丰富的核内假包涵体(14%)。
- 大多数NRTC FNA分类为可疑恶性或恶性(89%)。
- 1例分类为意义不明的异型性,经ThyroSeq测序鉴定出NTRK1融合。
关键数值与推荐
- NRTC FNA分类为可疑恶性或恶性者占89%。
- 混合结构模式占79%,纤维化占93%,嗜酸性胞质占36%,空泡状胞质占43%,核内假包涵体占14%。
- 超声低回声占87%,实性为主占53%,中央血供有限占27%,边界不清占67%,微钙化占67%。
临床怎么用
- 对于FNA显示混合结构模式、显著纤维化及特定胞质或核特征的甲状腺癌,应怀疑NRTC。
- 当细胞块BRAFV600E免疫组化阴性时,可依据上述特征选择病例进行分子检测以识别NRTC。
- 该算法方法可能有助于识别潜在NRTC,最大化治疗选择,尤其对于治疗计划复杂的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: NTRK-rearranged thyroid carcinomas (NRTC), though rare, harbor a potential therapeutic target. The cytomorphologic features by fine needle aspiration (FNA) and the utility of preoperative molecular testing for NRTC remain largely uncharacterized. We provide a detailed cytomorphologic analysis of an institutional NRTC cohort with clinical, radiologic, histopathologic, and molecular correlations. METHODS: Our NRTC FNA cohort included 21 specimens from 19 patients. The mean age and female-to-male ratio were 42 years and 2.2:1, respectively. Predominantly alcohol-stained Papanicolaou smears and liquid-based preparations were reviewed for 14 patients with available materials, and histologic review of subsequent resections was conducted for all 19 patients. Imaging and clinical data were accessed through electronic medical records. RESULTS: Sonographically, NRTC were hypoechoic (87%), predominantly solid (53%) with limited central vascularity (27%), ill-defined borders (67%), and microcalcifications (67%). Observed cytomorphologic features include mixed architectural patterns (79%), fibrosis (93%), oncocytic and vacuolated cytoplasm (36% and 43%, respectively), and abundant intranuclear pseudoinclusions (14%). Most NRTC FNAs were classified as suspicious for malignancy or malignant (89%). One case classified as atypia of uncertain significance underwent ThyroSeq sequencing where a NTRK1 fusion was identified. CONCLUSION: Although NRTC did not show a consistent cytomorphologic signature, mixed architectural patterns, prominent fibrosis and distinct cytoplasmic or nuclear features should raise suspicion for NRTC and, when accompanied by negative BRAFV600E by immunohistochemistry on cell block material, aid in selecting cases for molecular testing. This algorithmic approach may help identify potential NRTC, maximizing treatment options for patients, especially in patients for whom treatment planning is complicated.
引用
- Viswanathan K, Chu YH, Faquin WC, et al. Cytomorphologic features of NTRK-rearranged thyroid carcinoma. Cancer Cytopathol. 2020. PMID: 33074583. doi:10.1002/cncy.22374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。